Cross-sectional evaluation of a lateral flow assay for point-of-care detection of Neisseria gonorrhoeae in asymptomatic individuals at primary healthcare facilities in South Africa
- 9 February 2026
- journal article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 102 (Suppl 2) , s52-s55
Abstract
Objectives: Neisseria gonorrhoeae infection is a global health concern. An affordable and rapid point-of-care test is essential to optimise clinical care and could be used to detect and treat asymptomatic infection. Previously, a novel lateral flow assay for N. gonorrhoeae infection (NG LFA) met WHO test performance requirements in a symptomatic population. This study aimed to determine the performance of the NG LFA for detection of N. gonorrhoeae in people without symptoms. Methods: In this cross-sectional study, we evaluated a novel N. gonorrhoeae lateral flow assay in urine from 500 asymptomatic men and vaginal swabs from 400 asymptomatic women in South Africa. Individuals visiting four primary healthcare facilities in the Buffalo City district, South Africa were enrolled if they were adults (18–49 years) and did not report any genitourinary symptoms, regardless of the reason for visiting the facility. First-void urine specimens and nurse-collected vaginal swabs were tested onsite with the NG-LFA and compared with the Xpert CT/NG assay. Discordant specimens were further investigated. Results: Between March and July 2023, we enrolled 500 male and 400 female participants. The median age of male participants was 21 years (range: 18–49 years), and female participants, 32 years (range: 18–49 years). In urine specimens, NG-LFA sensitivity was 80.6% (Wilson 95% CI 63.7 to 90.8) and 81.8% in vaginal swab specimens (65·6–91.4). The specificity was 94.2% in urine specimens (91.8 to 96.0) and 98.1% in vaginal specimens (96.1 to 99.1). All NG-LFA positive/Xpert negative cases were negative for N. gonorrhoeae or other Neisseria species in additional molecular testing. Conclusions: The NG LFA in vaginal swab specimens met WHO criteria for a screening test in low-resource settings. The NG LFA in male urine specimens met sensitivity criteria but did not meet the criteria for specificity.Keywords
Funding Information
- Global AMR Innovation Fund
- UK International Development via FIND
This publication has 13 references indexed in Scilit:
- Point-of-care testing to strengthen sexually transmitted infection case management in resource-constrained settingsSexually Transmitted Infections, 2026
- High prevalence and incidence of curable sexually transmitted infections among young women using oral HIV pre-exposure prophylaxis in sub-Saharan Africa: results from the INSIGHT Cohort studySexually Transmitted Infections, 2025
- Innovations in the biomedical prevention, diagnosis, and service delivery of HIV and other sexually transmitted infectionsThe Lancet, 2025
- Evaluation of a novel point-of-care lateral flow assay screening for Neisseria gonorrhoeae infection among pregnant women in ZimbabwePLOS Global Public Health, 2025
- Novel lateral flow assay for point-of-care detection of Neisseria gonorrhoeae infection in syndromic management settings: a cross-sectional performance evaluationThe Lancet, 2024
- Development of a Novel Fluorescent-Based Lateral Flow Assay for the Detection of Neisseria gonorrhoeae at the Point of CareSexually Transmitted Diseases, 2023
- Same-Day Treatment Following Point-of-Care Sexually Transmitted Infection Testing in Different Healthcare Settings in South AfricaClinical Infectious Diseases, 2022
- Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensusPLOS ONE, 2020
- Diagnosing sexually transmitted infections in resource‐constrained settings: challenges and ways forwardJournal of the International AIDS Society, 2019
- Adult gonorrhea, chlamydia and syphilis prevalence, incidence, treatment and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990-2017PLOS ONE, 2018